What is Tech Adaptive Pandit?

Tech Adaptive Pandit Pty Ltd is an Australia-based MedTech and AI company specializing in Generative AI, Deep Learning, Multi-Agent AI, and digital healthcare solutions. We build scalable, real-time AI products including MedLipi for healthcare, Digital Guru for education, and KrishiShod for agriculture.

What is MedLipi and how does it help Australian doctors?

MedLipi is an AI-powered clinical intelligence platform built for Australian doctors. It provides real-time voice-to-text clinical documentation, AI-assisted differential diagnosis, adaptive treatment recommendations, MBS billing integration, ATSI health assessments, and support for 30+ medical specialties — reducing documentation time by up to 60%.

What AI services does Tech Adaptive Pandit offer in Australia?

Tech Adaptive Pandit offers Generative AI solutions, Deep Learning solutions, Multi-Agent AI systems, Explainable AI (XAI), AI clinical documentation, AI-powered personalized learning, and AI crop health prediction — serving healthcare, education, and agriculture industries across Australia and globally.

Where is Tech Adaptive Pandit located?

Tech Adaptive Pandit Pty Ltd is headquartered in Adelaide, South Australia, and serves clients globally across healthcare, education, and agriculture sectors.

Is Tech Adaptive Pandit's AI compliant with healthcare standards?

Yes. Our AI solutions are built to be compliant with global standards including HIPAA and GDPR. MedLipi is designed for the Australian healthcare system with MBS billing, PBS integration, My Health Record readiness, and RACGP guideline compliance.

Pre-Seed Pitch Deck · March 2026

CONFIDENTIAL · PRE-SEED ROUND · MARCH 2026

MedLipi

Australia's AI Clinical Intelligence Platform

Real-time clinical documentation, Medicare billing optimisation, and multi-specialty AI — purpose-built for the Australian healthcare system.

Clinicians Active on MVP

$800K

Raising AUD

$2B+

Australian TAM

25+

Specialty Modules

investors@medlipi.com.au · www.medlipi.com.auSlide 1 of 14

The Problem

Australia Has a GP Crisis —
And Paperwork Is Making It Worse

2–3 hrs

Daily documentation per GP

Every consultation generates 10–15 minutes of paperwork — notes, coding, referrals, billing.

1.2M

Australians without a GP

GP shortage is directly linked to burnout from administrative overload.

26%

GPs planning early retirement

Not due to patient care — due to the crushing administrative burden.

$2B

Annual cost of GP burnout

Lost productivity, recruitment, and patient outcomes across the Australian system.

💡 US tools like Nuance DAX, Abridge, and Nabla exist — but none are built for Australia. No Medicare/MBS. No My Health Record. No RACGP compliance.

investors@medlipi.com.au · www.medlipi.com.auSlide 2 of 14

The Solution

MedLipi: Clinical AI Built
for Australian Healthcare

One platform. Every specialty. Full compliance.

🎙️

Voice-to-Note

Real-time transcription → complete SOAP notes in under 30 seconds, in 100+ languages.

🏥

MBS Billing

Planned post-funding: optimal Medicare item code suggestions to help GPs optimise billing accuracy.

🔗

My Health Record

Planned post-funding: FHIR R5 compliant integration with the national digital health record.

🧠

25+ Specialties

From cardiology to psychiatry — specialty-specific AI modules for each clinical context.

🛡️

100% Australian

Data sovereignty on AWS Sydney. RACGP guidelines built in. HIPAA compliant.

🤖

Multi-Agent AI

Specialist AI agents collaborate in real-time — cardiology, psychiatry, billing agents working in parallel.

investors@medlipi.com.au · www.medlipi.com.auSlide 3 of 14

Unique Selling Point

Why MedLipi Wins —
No Other Tool Does This in Australia

We're not just an AI scribe. We're Australia's only end-to-end clinical intelligence platform.

🇦🇺

Built for Australia, Only

MBS Medicare codes, PBS drug database, My Health Record API, RACGP clinical guidelines — all natively integrated. Zero configuration for Australian GPs.

🗣️

100+ Language Voice AI

Clinicians speak in any language — the system produces clinical notes in perfect medical English. Critical for multicultural Australian healthcare.

🧠

Multi-Agent AI Architecture

Unique multi-agent AI system where specialist AI agents collaborate — cardiology agent, psychiatry agent, billing agent — all working in parallel for each consultation.

💰

3x Cheaper Than US Alternatives

At $199–299/month AUD vs $750–1,050 for Nuance DAX, MedLipi delivers superior Australian-specific value at a fraction of the price.

🔒

Data Sovereignty Guaranteed

All clinical data remains in Australia on AWS Sydney. Zero data leaves Australian jurisdiction — mandatory for hospital contracts and compliance.

⚡

Real-Time, Not Post-Visit

Notes generated during the consultation — not after. Doctors leave with complete documentation before the patient leaves the room.

🔬

AI Differential Diagnosis

MedLipi's multi-agent AI suggests differential diagnoses in real-time — highlighting the most likely conditions ranked by clinical probability using Explainable AI.

😊

Sentiment & Emotion Analysis

Unique sentiment AI detects patient anxiety, distress, or confusion during consultations — prompting clinicians to adapt their approach in real-time.

🌍

Country-Specific Medication AI

Medication recommendations are localised to Australia (MBS), India (NLEM), UK (BNF), and more — ensuring clinicians get country-relevant drug guidance.

🧩

Explainable AI (XAI)

Every AI recommendation comes with a clinical explanation — why the AI suggested it, what evidence supports it, and what the confidence level is. No black-box AI.

investors@medlipi.com.au · www.medlipi.com.auSlide 4 of 14

Traction — This Is Real

52 Clinicians Active on MVP.

Not a prototype. Not a pilot proposal. Clinicians are using MedLipi today.

Active on MVP

Using platform now

60–65%

Less Paperwork

Per consult

Clinically

Acceptable

Clinical Accuracy

Clinician-validated

14min

Saved/Consult

Avg per doctor

🚀 Scaling Roadmap — RACGP & My Health Record Approvals In Progress

RACGP Endorsement

🔜 Post-Funding

Will drive mass adoption via RACGP member network (26,000 GPs)

→ 26,000 GPs

My Health Record API

🔜 Post-Funding

Will enable enterprise contracts with hospital networks & DHBs

→ Enterprise tier

Hospital & PHN Contracts

🔜 Post-Funding

Will enable bulk licensing and EHR integration across 31 PHNs

→ Hospital Networks

✅ Product Milestones

• MVP live — 52 clinicians using it daily
• 25+ specialty modules deployed
• 100+ language voice recognition active
• MBS billing + My Health Record — planned post-funding

✅ Market Validation

• 52 clinicians active on MVP (organic, no paid marketing)
• University of Adelaide partnership confirmed
• RACGP endorsement pathway confirmed
• My Health Record API integration planned

investors@medlipi.com.au · www.medlipi.com.auSlide 5 of 14

Market Opportunity

$2B+ Total Addressable Market

Starting with 26,000 Australian GPs — expanding to specialists, hospitals, aged care, and Asia-Pacific.

TAM — Total Addressable Market

$2B+

All Australian clinicians — GPs, specialists, hospitals, aged care + NZ/SE Asia

SAM — Serviceable Addressable Market

$680M

26,000 Australian GPs × $2,600/year average ARR

SOM — Serviceable Obtainable (Yr 3)

$2.3M

~900 GPs at $2,600/year ARR — 3.5% GP market share

📈 Expansion Markets

🏥 Hospital Networks (PHNs)$180M

👴 Aged Care Facilities$240M

🩺 Specialists (all)$410M

🌏 NZ / SE Asia expansion$300M+

⚡ Why Now?

✅ Working product — 52 clinicians already active
✅ AI scribe category proven globally ($150M+ raises)
✅ No Australian competitor with full compliance
✅ Government pushing digital health (My Health Record)
✅ GP shortage creates urgency to act now

investors@medlipi.com.au · www.medlipi.com.auSlide 6 of 14

Financial Projections

EBITDA Positive by Year 3

Metric	Year 1	Year 2	Year 3
Active Doctors	150	420	900
ARR	$360K	$1.0M	$2.3M
Gross Margin	72%	78%	82%
EBITDA	–$480K	–$120K	+$200K
Monthly Burn	$40K	$15K	Cash Flow+

Exit Scenarios (Year 4–5)

Strategic acquisition (Telstra Health / Sonic)$15–25M

US strategic (Epic, Nuance, Microsoft)$25–50M

Return on $800K pre-seed (19–62x)$15–50M

Comparable Transactions

Nuance (acquired by Microsoft)$19.7B

Abridge Series C raise$150M

Nabla Series B raise€30M

Suki AI valuation$400M+

investors@medlipi.com.au · www.medlipi.com.auSlide 7 of 14

Competitive Landscape

How We're Different — Australia & Globally

Including Australian competitors Heidi Health & Lyrebird Health — MedLipi leads on depth, AI architecture, and roadmap.

Feature	MedLipi 🇦🇺	Heidi 🇦🇺	Lyrebird 🇦🇺	Nuance 🇺🇸	Abridge 🇺🇸	Nabla 🇫🇷
MBS/Medicare (Post-fund)	🔜 Planned	⚠️ Partial	⚠️ Partial	❌ None	❌ None	❌ None
My Health Record	🔜 Planned	❌ No	❌ No	❌ None	❌ None	❌ None
RACGP Guidelines	✅ Built-in	⚠️ Partial	⚠️ Partial	❌ None	❌ None	❌ None
Data Sovereignty (AU)	✅ AWS Sydney	✅ AU	✅ AU	⚠️ US	⚠️ US	⚠️ EU
100+ Languages	✅ Yes	❌ No	❌ No	⚠️ Limited	⚠️ Limited	⚠️ Limited
Price (AUD/month)	✅ $199–299	⚠️ $299+	⚠️ $250+	❌ $750–1,050	❌ $600–900	❌ $500–800
25+ Specialty Modules	✅ Yes	❌ GP only	❌ GP only	⚠️ Partial	⚠️ Partial	⚠️ Partial
Multi-Agent AI	✅ Unique	❌ No	❌ No	❌ No	❌ No	❌ No
AI Differential Diagnosis	✅ Built-in	❌ No	❌ No	⚠️ Basic	❌ No	❌ No
Sentiment / Emotion AI	✅ Built-in	❌ No	❌ No	❌ No	❌ No	❌ No
Country-Specific Medication	✅ Yes (AU+)	❌ No	❌ No	❌ No	❌ No	❌ No
Explainable AI (XAI)	✅ Full XAI	❌ No	❌ No	❌ No	❌ No	❌ No
Futuristic AI Roadmap	✅ Strong	⚠️ Basic	⚠️ Basic	⚠️ Moderate	⚠️ Moderate	⚠️ Basic

🏆 vs Australian Competitors: Heidi & Lyrebird are basic GP scribes — no differential diagnosis, no sentiment AI, no XAI, no country-specific medications, no multi-agent architecture. vs Global: US/EU tools have zero Australian compliance. MedLipi is in a category of its own.

investors@medlipi.com.au · www.medlipi.com.auSlide 8 of 14

Subscription Model

Simple SaaS. Exceptional Unit Economics.

Bottoms-Up. Then Enterprise.

Phase 1 — NOW

Adelaide GP Pilot (50–100 GPs)

Direct outreach to Adelaide GPs. Free pilot + University of Adelaide clinical study. Build case studies, testimonials, and clinical evidence.

Phase 2 — 6mo

National Direct Sales (150 GPs)

LinkedIn + GP community + RACGP conference. Convert pilot data into paid subscriptions. $12K MRR target.

Phase 3 — 12mo

Hospital & PHN Contracts

Leverage RACGP endorsement + clinical study. Pitch to 31 Primary Health Networks (PHNs) across Australia. Enterprise-tier deals.

Phase 4 — 24mo

NZ + SE Asia Expansion

Use Australian playbook in New Zealand, Singapore, and Malaysia. Partner with local healthcare distributors.

🎯 Acquisition Channels

• Direct: GP community groups, RACGP conference, LinkedIn
• Referral: Doctor-to-doctor word of mouth (14min saved = viral)
• Partnerships: Medical software vendors (Best Practice, Medical Director)
• Academic: University of Adelaide clinical study participants
• PHNs: Group contracts across 31 regional health networks

📊 Revenue Milestones

Month 6$12K MRR60 GPs

Month 12$30K MRR150 GPs

Month 18$65K MRR300 GPs

Month 24$120K MRR550 GPs

investors@medlipi.com.au · www.medlipi.com.auSlide 10 of 14

Futuristic Insights

The Next Frontier of Clinical AI

MedLipi is building the infrastructure for the next generation of AI-powered healthcare — beyond documentation.

🤖

2026

Autonomous Multi-Agent Diagnostics

Multiple AI agents collaborate in real-time — one analyses symptoms, another checks drug interactions, a third codes billing — all simultaneously during a consultation.

🧬

2026

Predictive Clinical Intelligence

AI learns from 52+ clinician patterns to predict diagnoses, flag high-risk patients before symptoms escalate, and recommend preventive interventions proactively.

🌐

2027

Federated Learning Across Hospitals

AI improves from anonymised patterns across all hospitals — without sharing patient data. Each hospital's AI gets smarter from the entire network.

📱

2027

Ambient Clinical Intelligence

Passive AI always-on in consultation rooms — no manual recording needed. Entire clinical workflow captured, coded, and documented automatically.

🔮

2028

Predictive Population Health

AI analyses population-level patterns across clinics to predict disease outbreaks, seasonal surges, and high-risk patient cohorts before they present.

🌏

2028

Asia-Pacific Clinical AI Hub

MedLipi becomes the regulatory-compliant AI infrastructure for all Asia-Pacific healthcare — NZ, Singapore, Malaysia, India — using Australia as the compliance launchpad.

🚀 Vision: MedLipi becomes the AI operating system for every clinical encounter in Australia — and the Asia-Pacific region.

investors@medlipi.com.au · www.medlipi.com.auSlide 11 of 14

Founders & Team

Built by Healthcare & AI Experts

Deep domain expertise across clinical AI research, healthcare systems, and Australian regulatory pathways.

Dr. Manish Gupta

Founder & CEO

12+ yrsAI Research — Explainable AI, Multi-Agent AI, Agentic AI systems

Ex-Digital Healthcare specialist — clinical intelligence platforms & AI diagnostics

🏆Deep expertise in healthcare AI architecture, clinical NLP, and regulatory compliance

Gourav Gupta

Co-Founder & CTO

7+ yrsExplainable AI, Machine Learning & Deep Learning Research

Ex-Digital Healthcare — ML/AI research, clinical systems engineering

🔬Expert in AI model architecture, clinical NLP, and scalable healthcare AI infrastructure

Advisory Board & Partners

🏛️ University of Adelaide — Clinical research partner. Validation study lead.

🩺 RACGP Advisors — Practising GPs advising on clinical accuracy and workflow.

investors@medlipi.com.au · www.medlipi.com.auSlide 12 of 14

Our Customers

Who Uses MedLipi?

From solo GPs to hospital networks — MedLipi serves every clinical setting in Australia.

👨‍⚕️

PRIMARY MARKET

General Practitioners

26,000+ in Australia

Pain: 2–3 hrs daily paperwork, MBS billing errors, GP shortage crisis

Value: Save 14 min/consult, perfect MBS coding, reduce burnout

Solo GP practicesGroup GP clinicsBulk billing centresAfter-hours clinics

🏥

ENTERPRISE

Hospital Networks & PHNs

31 PHNs + 700+ public hospitals

Pain: High documentation burden, compliance risk, audit exposure

Value: Bulk licensing, EHR integration, audit trails, white-labelling

Primary Health NetworksPublic hospital wardsEmergency departmentsOutpatient clinics

🩺

GROWTH MARKET

Specialists & Consultants

30,000+ specialists in Australia

Pain: Complex specialty notes, high medicolegal risk, referral letters

Value: 25+ specialty modules — cardiology, psychiatry, oncology & more

CardiologistsPsychiatristsOncologistsOrthopaedic surgeons

👴

EXPANSION

Aged Care Facilities

2,700+ aged care facilities

Pain: Understaffed, high documentation burden, compliance with Aged Care Quality Standards

Value: Digital nurse AI, medication management, ACQS compliance

Residential aged careMemory care unitsPalliative careRetirement villages

🌏

UNIQUE ADVANTAGE

Multicultural Clinics

1 in 3 Australians speaks a language other than English

Pain: Language barriers, miscommunication, poor clinical handover

Value: 100+ language voice AI — speak in any language, notes in English

Multicultural GP practicesMigrant health clinicsInterpreter-reliant servicesCommunity health centres

🎓

PARTNERSHIP

Medical Schools & Researchers

University of Adelaide — confirmed partner

Pain: Manual data collection, inconsistent clinical documentation, research gaps

Value: AI-generated structured data, anonymised research datasets, clinical studies

University of AdelaideMedical research institutesClinical training programsHealth tech accelerators

🎯 Beachhead: Australian GPs (26,000) → Specialists & PHNs → Aged Care & Hospitals → NZ & SE Asia

investors@medlipi.com.au · www.medlipi.com.auSlide 13 of 14

The Ask

Raising $800K AUD

Pre-Seed Round · Pre-Money Valuation: $3M AUD

Use of Funds

Regulatory & Compliance

30%

$240K

Adelaide Pilot + Clinical Study

20%

$160K

My Health Record + EHR Integration

20%

$160K

Sales & Marketing (GP acquisition)

20%

$160K

Team & Operations

10%

$80K

What Investors Get

✅ Equity in Australia's only compliant AI scribe
✅ First-mover regulatory moat vs US giants
✅ 52 clinicians active on MVP (no paid marketing)
✅ 19–62x return potential (exit $15–50M)
✅ University of Adelaide validation study
✅ 18+ month runway on $800K pre-seed

Ready to Invest?

Request our full financial model + data room

📧 investors@medlipi.com.au

🌐 www.medlipi.com.au

investors@medlipi.com.au · www.medlipi.com.au · ConfidentialSlide 14 of 14

MedLipi

Australia's AI Clinical Intelligence Platform

Australia Has a GP Crisis —And Paperwork Is Making It Worse

MedLipi: Clinical AI Builtfor Australian Healthcare

Why MedLipi Wins —No Other Tool Does This in Australia

52 Clinicians Active on MVP.

$2B+ Total Addressable Market

EBITDA Positive by Year 3

How We're Different — Australia & Globally

Simple SaaS. Exceptional Unit Economics.

Bottoms-Up. Then Enterprise.

The Next Frontier of Clinical AI

Built by Healthcare & AI Experts

Who Uses MedLipi?

Raising $800K AUD

Australia Has a GP Crisis —
And Paperwork Is Making It Worse

MedLipi: Clinical AI Built
for Australian Healthcare

Why MedLipi Wins —
No Other Tool Does This in Australia